Sourcing Disclosure: Licensed Bangladesh Global Sourcing Specialist facilitating global access under Named Patient Regulations. Expert-reviewed clinical data for prescription-only medicine.

Salma Abdel, Evidence-Based Medical Researcher

Healthcare professional with over 13 years of experience in hospital and healthcare administration environments. Skilled in Quality Management System Implementation , ISO 9001 and ISO 45001 compliance, Internal Auditing, Risk assessment, CAPA management, KPI monitoring, Oncology Product analysis and Product Leaflet writing.

Joined: March 1, 2026
Articles: 20

Uncategorized

Understanding jak inhibitor vitiligo cream and treatment

mechanism of jak inhibitor vitiligo cream

Vitiligo is a skin condition that affects millions worldwide. It causes patches of skin to lose their color. This can lead to significant emotional and psychological distress. Recent advancements in treatment offer new hope. Jak inhibitors, a class of medication,…

Salma Abdel, Evidence-Based Medical Researcher
May 15, 2026

Uncategorized

How to Remove Eczema Scars Naturally: Proven Home Remedies

Eczema scars can be a persistent reminder of past flare-ups. Many people seek natural ways to heal these scars and to heal eczema scars without harsh products. Natural remedies offer a gentle approach to skin care with practical scar removal…

Salma Abdel, Evidence-Based Medical Researcher
May 15, 2026

Uncategorized

Understanding the Benefits of Vitiligo Cream

Vitiligo is a skin condition that affects millions worldwide. It causes patches of skin to lose their color. This can lead to noticeable white spots on various parts of the body. For those living with vitiligo, finding effective treatment is…

Salma Abdel, Evidence-Based Medical Researcher
May 15, 2026

Oncology Medication Storing

Storing and Handling Oral Oncology Medications at Home

Salma Abdel, Evidence-Based Medical Researcher
March 30, 2026

Blog, PARP Inhibitors in BRCA mutations

Molecular Mechanisms of Synthetic Lethality: A Clinical Review of PARP Inhibition in BRCA-Mutated Malignancies

Diagram of synthetic lethality mechanism: PARP inhibition in BRCA-mutant cancer cells leading to apoptosis vs. survival in healthy cells.

Medically Reviewed by: Dr. Salma Elreedy, Clinical Oncologist, Sphinx Cure Oncology Center. Fact-Checked by: Generic Oncology Editorial Team. Synthetic lethality is a genetic phenomenon where the simultaneous loss of function in two separate genes results in cell death, while the…

Salma Abdel, Evidence-Based Medical Researcher
March 28, 2026

Supportive & Palliative Care, Blog

Supportive and Palliative Oncology: Clinical Protocols for Quality of Life

chemotherapy induced nausea and vomitting prevention diagram in Supportive and Palliative Oncology

Protocol Overview Historically, the discipline of clinical oncology maintained a singular, aggressive focus on tumor eradication. The primary metric of success was the reduction of tumor burden, often at the severe expense of the patient’s physical and psychological tolerance. Today,…

Salma Abdel, Evidence-Based Medical Researcher
March 26, 2026

Blog, Generic oncolgoy medicines

Evolving Production Standards and Accessibility in Generic Oncology Therapeutics

We have moved beyond the era where cancer care was defined strictly by high-cost, exclusive branded drugs accessible only to a small percentage of the global population. Today, the focus has shifted toward the democratization of treatment through scientific advancement…

Salma Abdel, Evidence-Based Medical Researcher
March 25, 2026

Generic oncolgoy medicines, Blog

Strategies for Managing and Reducing Cancer Medication Costs: A 2026 Guide

The financial burden of cancer medication costs is often described by the medical community as “Financial Toxicity.” This is not just a term for high bills; it is a clinical reality that affects how well a patient recovers. When the…

Salma Abdel, Evidence-Based Medical Researcher
March 23, 2026

Generic oncolgoy medicines

The Science of Identifying High-Quality Generic Oncology Medicines

High-Quality Generic Oncology Medicines verification infograph

In the year 2026, the global oncology market is saturated with options. While the availability of generic medications has made cancer treatment more affordable, it has also introduced a critical challenge for patients and healthcare providers: how to distinguish a…

Salma Abdel, Evidence-Based Medical Researcher
March 21, 2026

Janus Kinase Inhibitors

JAK Inhibitors | Patient Guide to Clinical Efficacy, Safety, and Treatment Outcomes

Medically Reviewed by: Dr. Salma Elreedy, MD (Clinical Oncology & Internal Medicine) Editorial Board: Generic Oncology Medical Review Board Disclaimer: This educational hub is for informational purposes only and does not constitute medical advice. Always consult your board-certified Rheumatologist, Gastroenterologist,…